The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
T cell response to SARS-CoV-2 infection in humans: A systematic review
Open accessAbstract
Background: Understanding the T cell response to SARS-CoV-2 is critical to vaccine development, epidemiological surveillance and disease control strategies. This systematic review critically evaluates and synthesises the relevant peer-reviewed and pre-print literature published from 01/01/2020-26/06/2020. Methods: For this systematic review, keyword-structured literature searches were carried out in MEDLINE, Embase and COVID-19 Primer. Papers were independently screened by two researchers, with arbitration of disagreements by a third researcher. Data were independently extracted into a pre-designed Excel template and studies critically appraised using a modified version of the MetaQAT tool, with resolution of disagreements by consensus. Findings were narratively synthesised. Results: 61 articles were included. 55 (90%) studies used observational designs, 50 (82%) involved hospitalised patients with higher acuity illness, and the majority had important limitations. Symptomatic adult COVID-19 cases consistently show peripheral T cell lymphopenia, which positively correlates with increased disease severity, duration of RNA positivity, and non-survival; while asymptomatic and paediatric cases display preserved counts. People with severe or critical disease generally develop more robust, virus-specific T cell responses. T cell memory and effector function has been demonstrated against multiple viral epitopes, and, cross-reactive T cell responses have been demonstrated in unexposed and uninfected adults, but the significance for protection and susceptibility, respectively, remains unclear. Conclusion: A complex pattern of T cell response to SARS-CoV-2 infection has been demonstrated, but inferences regarding population level immunity are hampered by significant methodological limitations and heterogeneity between studies, as well as a striking lack of research in asymptomatic or pauci-symptomatic individuals. In contrast to antibody responses, population-level surveillance of the T cell response is unlikely to be feasible in the near term. Focused evaluation in specific sub-groups, including vaccine recipients, should be prioritised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
WHO Coronavirus Disease (COVID-19) Dashboard
(2020) · Bangladesh Physiotherapy Journal · doi:10.46945/bpj.10.1.03.01 · Cited by 3,806
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · cited 1×
“At the time of searching, few studies had explored the relationship between T cells, age and clinical severity, with appropriate statistical adjustment, however, a recent study examining all three branches of the adaptive immune response (CD8 + T cells, CD4+ T cells, and neutralising antibodies), found that older age…”
BackgroundRobust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,702
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Anderson, E. J., Rouphael, N. G., Widge, A. T., Jackson, L. A., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2028436 · Cited by 1,523
Zhang, Y., Zeng, G., Pan, H., Li, C., Hu, Y., Chu, K., Han, W., Chen, Z., Tang, R., Yin, W., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30843-4 · Cited by 1,504
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2700-3 · Cited by 1,459
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc6952 · Cited by 1,385
Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., Wang, L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31208-3 · Cited by 1,382
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Stone, J. H., Frigault, M. J., Serling-Boyd, N. J., Fernandes, A. D., Harvey, L., Foulkes, A. S., Horick, N. K., Healy, B. C., Shah, R., Bensaci, A. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2028836 · Cited by 1,362
Ramasamy, M. N., Minassian, A. M., Ewer, K. J., Flaxman, A. L., Folegatti, P. M., Owens, D. R., Voysey, M., Aley, P. K., Angus, B., Babbage, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32466-1 · Cited by 1,324
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310
Rogers, T. F., Zhao, F., Huang, D., Beutler, N., Burns, A., He, W.-T., Limbo, O., Smith, C., Song, G., Woehl, J., et al. (2020) · Science · doi:10.1126/science.abc7520 · Cited by 1,230
Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31605-6 · Cited by 1,225
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Hansen, J., Baum, A., Pascal, K. E., Russo, V., Giordano, S., Wloga, E., Fulton, B. O., Yan, Y., Koon, K., Patel, K., et al. (2020) · Science · doi:10.1126/science.abd0827 · Cited by 1,210
Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., Geng, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.025 · Cited by 1,188
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179
Xia, S., Zhang, Y., Wang, Y., Wang, H., Yang, Y., Gao, G. F., Tan, W., Wu, G., Xu, M., Lou, Z., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30831-8 · Cited by 1,144
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science · doi:10.1126/science.abc5902 · Cited by 1,140
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120
Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques
McMahan, K., Yu, J., Mercado, N. B., Loos, C., Tostanoski, L. H., Chandrashekar, A., Liu, J., Peter, L., Atyeo, C., Zhu, A., et al. (2021) · Nature · doi:10.1038/s41586-020-03041-6 · Cited by 1,068
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ni, L., Ye, F., Cheng, M.-L., Feng, Y., Deng, Y.-Q., Zhao, H., Wei, P., Ge, J., Gou, M., Li, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.023 · Cited by 1,063
Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31866-3 · Cited by 1,055
Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Imai, M., Iwatsuki-Horimoto, K., Hatta, M., Loeber, S., Halfmann, P. J., Nakajima, N., Watanabe, T., Ujie, M., Takahashi, K., Ito, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009799117 · Cited by 1,021
Wu, Y., Wang, F., Shen, C., Peng, W., Li, D., Zhao, C., Li, Z., Li, S., Bi, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc2241 · Cited by 993
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907
Humoral Immune Response to SARS-CoV-2 in Iceland
Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026116 · Cited by 903
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886
Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc8413 · Cited by 868
Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., O'Reilly, K., Endo, A., Hellewell, J., Nightingale, E. S., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30133-x · Cited by 848
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.007 · Cited by 847
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Geppert, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., Bergman, H., Buckley, S. B., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 842
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe5511 · Cited by 822
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816 · cited 3×
“However, these findings to do not exclude the possibility that protection was antibody-dependent rather than due to T cell immunity exclusively, and longer-term analyses are needed [30].”
BackgroundAntibodies in Infants Born to Mothers With COVID-19 Pneumonia
Zeng, H., Xu, C., Fan, J., Tang, Y., Deng, Q., Zhang, W., & Long, X. (2020) · JAMA · doi:10.1001/jama.2020.4861 · Cited by 804
T cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797
Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., Xia, S., Ling, Y., Zhang, Y., Xun, J., Lu, L., et al. (2020) · doi:10.1101/2020.03.30.20047365 · Cited by 754
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen, W., Su, W., Tang, H., Le, W., Zhang, X., Zheng, Y., Liu, X., Xie, L., Li, J., Ye, J., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0168-9 · Cited by 730
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582
The laboratory tests and host immunity of COVID-19 patients with different severity of illness
Wang, F., Hou, H., Luo, Y., Tang, G., Wu, S., Huang, M., Liu, W., Zhu, Y., Lin, Q., Mao, L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137799 · Cited by 556
Weisberg, S. P., Connors, T. J., Zhu, Y., Baldwin, M. R., Lin, W.-H., Wontakal, S., Szabo, P. A., Wells, S. B., Dogra, P., Gray, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00826-9 · Cited by 548
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019
Xiang, F., Wang, X., He, X., Peng, Z., Yang, B., Zhang, J., Zhou, Q., Ye, H., Ma, Y., Li, H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa461 · Cited by 535
Zhang, B., Zhou, X., Zhu, C., Song, Y., Feng, F., Qiu, Y., Feng, J., Jia, Q., Song, Q., Zhu, B., et al. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00157 · Cited by 528
Serum IgA, IgM, and IgG responses in COVID-19
Ma, H., Zeng, W., He, H., Zhao, D., Jiang, D., Zhou, P., Cheng, L., Li, Y., Ma, X., & Jin, T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0474-z · Cited by 511
The many faces of the anti-COVID immune response
Vardhana, S. A., & Wolchok, J. D. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200678 · Cited by 509
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Suthar, M. S., Zimmerman, M. G., Kauffman, R. C., Mantus, G., Linderman, S. L., Hudson, W. H., Vanderheiden, A., Nyhoff, L., Davis, C. W., Adekunle, O., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100040 · Cited by 508
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138554 · Cited by 502
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
Sun, B., Feng, Y., Mo, X., Zheng, P., Wang, Q., Li, P., Peng, P., Liu, X., Chen, Z., Huang, H., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1762515 · Cited by 473
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
Lou, B., Li, T.-D., Zheng, S.-F., Su, Y.-Y., Li, Z.-Y., Liu, W., Yu, F., Ge, S.-X., Zou, Q.-D., Yuan, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00763-2020 · Cited by 472
Burbelo, P. D., Riedo, F. X., Morishima, C., Rawlings, S., Smith, D., Das, S., Strich, J. R., Chertow, D. S., Davey, R. T., & Cohen, J. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa273 · Cited by 471
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437
Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., et al. (2020) · doi:10.1101/2020.03.13.990226 · Cited by 419
Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S. (2014) · Journal of Virology · doi:10.1128/jvi.01505-14 · Cited by 411 · cited 1×
“Accompanying T cell dysregulation, a cytokine release syndrome (CRS)-like clinical picture occurs in many patients with severe SARS-CoV-2 infection [68].”
BackgroundGarcia-Basteiro, A. L., Moncunill, G., Tortajada, M., Vidal, M., Guinovart, C., Jiménez, A., Santano, R., Sanz, S., Méndez, S., Llupià, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17318-x · Cited by 408
Self-citationSystemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., Raeber, M. E., Adamo, S., Weigang, S., Emmenegger, M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.040 · Cited by 408
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Lv, H., Wu, N. C., Tsang, O. T.-Y., Yuan, M., Perera, R. A. P. M., Leung, W. S., So, R. T. Y., Chan, J. M. C., Yip, G. K., Chik, T. S. H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107725 · Cited by 407
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
Hou, H., Wang, T., Zhang, B., Luo, Y., Mao, L., Wang, F., Wu, S., & Sun, Z. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1136 · Cited by 398
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Zuo, J., Dowell, A. C., Pearce, H., Verma, K., Long, H. M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00902-8 · Cited by 392
Self-citationChen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.003 · Cited by 380
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244126 · Cited by 374
Self-citationWang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., & Wang, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa721 · Cited by 359
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells
Schulien, I., Kemming, J., Oberhardt, V., Wild, K., Seidel, L. M., Killmer, S., Sagar, Daul, F., Salvat Lago, M., Decker, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01143-2 · Cited by 357
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Pierce, C. A., Preston-Hurlburt, P., Dai, Y., Aschner, C. B., Cheshenko, N., Galen, B., Garforth, S. J., Herrera, N. G., Jangra, R. K., Morano, N. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5487 · Cited by 353
Kellam, P., & Barclay, W. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001439 · Cited by 351
Self-citationRipperger, T. J., Uhrlaub, J. L., Watanabe, M., Wong, R., Castaneda, Y., Pizzato, H. A., Thompson, M. R., Bradshaw, C., Weinkauf, C. C., Bime, C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.004 · Cited by 341
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
Ward, H., Atchison, C., Whitaker, M., Ainslie, K. E. C., Elliott, J., Okell, L., Redd, R., Ashby, D., Donnelly, C. A., Barclay, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21237-w · Cited by 337
Chen, X., Li, R., Pan, Z., Qian, C., Yang, Y., You, R., Zhao, J., Liu, P., Gao, L., Li, Z., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0426-7 · Cited by 332
Zeng, F., Dai, C., Cai, P., Wang, J., Xu, L., Li, J., Hu, G., Wang, Z., Zheng, F., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25989 · Cited by 330
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
Perera, R. A., Mok, C. K., Tsang, O. T., Lv, H., Ko, R. L., Wu, N. C., Yuan, M., Leung, W. S., Chan, J. M., Chik, T. S., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.16.2000421 · Cited by 322
Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318
Grzelak, L., Temmam, S., Planchais, C., Demeret, C., Tondeur, L., Huon, C., Guivel-Benhassine, F., Staropoli, I., Chazal, M., Dufloo, J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc3103 · Cited by 310
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
Padoan, A., Sciacovelli, L., Basso, D., Negrini, D., Zuin, S., Cosma, C., Faggian, D., Matricardi, P., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.026 · Cited by 309
Kreer, C., Zehner, M., Weber, T., Ercanoglu, M. S., Gieselmann, L., Rohde, C., Halwe, S., Korenkov, M., Schommers, P., Vanshylla, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.044 · Cited by 309
The Role of Antibody Testing for SARS-CoV-2: Is There One?
Theel, E. S., Slev, P., Wheeler, S., Couturier, M. R., Wong, S. J., & Kadkhoda, K. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00797-20 · Cited by 305
Qu, J., Wu, C., Li, X., Zhang, G., Jiang, Z., Li, X., Zhu, Q., & Liu, L. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa489 · Cited by 303
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Rudberg, A.-S., Havervall, S., Månberg, A., Jernbom Falk, A., Aguilera, K., Ng, H., Gabrielsson, L., Salomonsson, A.-C., Hanke, L., Murrell, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18848-0 · Cited by 303
Viral Kinetics and Antibody Responses in Patients with COVID-19
Tan, W., Lu, Y., Zhang, J., Wang, J., Dan, Y., Tan, Z., He, X., Qian, C., Sun, Q., Hu, Q., et al. (2020) · medRxiv · doi:10.1101/2020.03.24.20042382 · Cited by 301
XU, B., FAN, C.-Y., WANG, A.-L., ZOU, Y.-L., YU, Y.-H., HE, C., XIA, W.-G., ZHANG, J.-X., & MIAO, Q. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.012 · Cited by 299
Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
Jin, Y., Wang, M., Zuo, Z., Fan, C., Ye, F., Cai, Z., Wang, Y., Cui, H., Pan, K., & Xu, A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.065 · Cited by 298
Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk
Fox, A., Marino, J., Amanat, F., Krammer, F., Hahn-Holbrook, J., Zolla-Pazner, S., & Powell, R. L. (2020) · iScience · doi:10.1016/j.isci.2020.101735 · Cited by 292
Prolonged virus shedding even after seroconversion in a patient with COVID-19
Liu, W.-D., Chang, S.-Y., Wang, J.-T., Tsai, M.-J., Hung, C.-C., Hsu, C.-L., & Chang, S.-C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.063 · Cited by 283
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams, E. R., Ainsworth, M., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E., Beer, S., Bell, J. I., Berry, T., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15927.1 · Cited by 278
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272
Gallais, F., Velay, A., Nazon, C., Wendling, M.-J., Partisani, M., Sibilia, J., Candon, S., & Fafi-Kremer, S. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2701.203611 · Cited by 267
Yongchen, Z., Shen, H., Wang, X., Shi, X., Li, Y., Yan, J., Chen, Y., & Gu, B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1756699 · Cited by 266
Cross-reactive memory T cells and herd immunity to SARS-CoV-2
Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00460-4 · Cited by 260
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Li, K., Huang, B., Wu, M., Zhong, A., Li, L., Cai, Y., Wang, Z., Wu, L., Zhu, M., Li, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19943-y · Cited by 260
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
Altmann, D. M., & Boyton, R. J. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6160 · Cited by 251
Profile of specific antibodies to SARS-CoV-2: The first report
Xiao, A. T., Gao, C., & Zhang, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.012 · Cited by 245
The clinical course and its correlated immune status in COVID-19 pneumonia
He, R., Lu, Z., Zhang, L., Fan, T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104361 · Cited by 241
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Mann, E. R., Menon, M., Knight, S. B., Konkel, J. E., Jagger, C., Shaw, T. N., Krishnan, S., Rattray, M., Ustianowski, A., Bakerly, N. D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6197 · Cited by 241
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D., Titov, A., Peshkova, I. O., Khmelevskaya, A., Dianov, D. V., Malasheva, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.004 · Cited by 233
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Agrati, C., Sacchi, A., Bordoni, V., Cimini, E., Notari, S., Grassi, G., Casetti, R., Tartaglia, E., Lalle, E., D’Abramo, A., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0572-6 · Cited by 229
Liu, Z., Long, W., Tu, M., Chen, S., Huang, Y., Wang, S., Zhou, W., Chen, D., Zhou, L., Wang, M., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.054 · Cited by 222
The impact of sex and gender on immunotherapy outcomes
Klein, S. L., & Morgan, R. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00301-y · Cited by 213
Lynch, K. L., Whitman, J. D., Lacanienta, N. P., Beckerdite, E. W., Kastner, S. A., Shy, B. R., Goldgof, G. M., Levine, A. G., Bapat, S. P., Stramer, S. L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa979 · Cited by 212
T‐cell responses and therapies against SARS‐CoV‐2 infection
Toor, S. M., Saleh, R., Sasidharan Nair, V., Taha, R. Z., & Elkord, E. (2021) · Immunology · doi:10.1111/imm.13262 · Cited by 207
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Prévost, J., Gasser, R., Beaudoin-Bussières, G., Richard, J., Duerr, R., Laumaea, A., Anand, S. P., Goyette, G., Benlarbi, M., Ding, S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100126 · Cited by 206
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients
Chen, Y., Tong, X., Wang, J., Huang, W., Yin, S., Huang, R., Yang, H., Chen, Y., Huang, A., Liu, Y., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.067 · Cited by 201
Carsetti, R., Zaffina, S., Piano Mortari, E., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610300 · Cited by 197
Payne, D. C., Smith-Jeffcoat, S. E., Nowak, G., Chukwuma, U., Geibe, J. R., Hawkins, R. J., Johnson, J. A., Thornburg, N. J., Schiffer, J., Weiner, Z., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6923e4 · Cited by 195
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution
Wang, H., Wu, X., Zhang, X., Hou, X., Liang, T., Wang, D., Teng, F., Dai, J., Duan, H., Guo, S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00742 · Cited by 193
Sherina, N., Piralla, A., Du, L., Wan, H., Kumagai-Braesch, M., Andréll, J., Braesch-Andersen, S., Cassaniti, I., Percivalle, E., Sarasini, A., et al. (2021) · Med · doi:10.1016/j.medj.2021.02.001 · Cited by 193
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China
Du, W., Yu, J., Wang, H., Zhang, X., Zhang, S., Li, Q., & Zhang, Z. (2020) · Infection · doi:10.1007/s15010-020-01427-2 · Cited by 191
Ryan, K. A., Bewley, K. R., Fotheringham, S. A., Slack, G. S., Brown, P., Hall, Y., Wand, N. I., Marriott, A. C., Cavell, B. E., Tree, J. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20439-y · Cited by 191
Neidleman, J., Luo, X., Frouard, J., Xie, G., Gill, G., Stein, E. S., McGregor, M., Ma, T., George, A. F., Kosters, A., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100081 · Cited by 188
Luchsinger, L. L., Ransegnola, B. P., Jin, D. K., Muecksch, F., Weisblum, Y., Bao, W., George, P. J., Rodriguez, M., Tricoche, N., Schmidt, F., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02005-20 · Cited by 187
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Ng, D. L., Goldgof, G. M., Shy, B. R., Levine, A. G., Balcerek, J., Bapat, S. P., Prostko, J., Rodgers, M., Coller, K., Pearce, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18468-8 · Cited by 185
Thieme, C. J., Anft, M., Paniskaki, K., Blazquez-Navarro, A., Doevelaar, A., Seibert, F. S., Hoelzer, B., Konik, M. J., Berger, M. M., Brenner, T., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100092 · Cited by 184
Xie, J., Ding, C., Li, J., Wang, Y., Guo, H., Lu, Z., Wang, J., Zheng, C., Jin, T., Gao, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25930 · Cited by 183
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Selva, K. J., van de Sandt, C. E., Lemke, M. M., Lee, C. Y., Shoffner, S. K., Chua, B. Y., Davis, S. K., Nguyen, T. H. O., Rowntree, L. C., Hensen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22236-7 · Cited by 181
Du, H., Dong, X., Zhang, J., Cao, Y., Akdis, M., Huang, P., Chen, H., Li, Y., Liu, G., Akdis, C. A., et al. (2021) · Allergy · doi:10.1111/all.14452 · Cited by 180
Rijkers, G., Murk, J.-L., Wintermans, B., van Looy, B., van den Berge, M., Veenemans, J., Stohr, J., Reusken, C., van der Pol, P., & Reimerink, J. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa463 · Cited by 176
Lu, J., Peng, J., Xiong, Q., Liu, Z., Lin, H., Tan, X., Kang, M., Yuan, R., Zeng, L., Zhou, P., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102960 · Cited by 176
Percivalle, E., Cambiè, G., Cassaniti, I., Nepita, E. V., Maserati, R., Ferrari, A., Di Martino, R., Isernia, P., Mojoli, F., Bruno, R., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.24.2001031 · Cited by 171
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Hurlburt, N. K., Seydoux, E., Wan, Y.-H., Edara, V. V., Stuart, A. B., Feng, J., Suthar, M. S., McGuire, A. T., Stamatatos, L., & Pancera, M. (2020) · Nature Communications · doi:10.1038/s41467-020-19231-9 · Cited by 171
Review of Current Advances in Serologic Testing for COVID-19
Espejo, A. P., Akgun, Y., Al Mana, A. F., Tjendra, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa112 · Cited by 167
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19
Bao, J., Li, C., Zhang, K., Kang, H., Chen, W., & Gu, B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.009 · Cited by 166
Liu, Y., Liao, W., Wan, L., Xiang, T., & Zhang, W. (2021) · Viral Immunology · doi:10.1089/vim.2020.0062 · Cited by 165
Jiang, M., Guo, Y., Luo, Q., Huang, Z., Zhao, R., Liu, S., Le, A., Li, J., & Wan, L. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa252 · Cited by 162
Increased expression of CD8 marker on T-cells in COVID-19 patients
Ganji, A., Farahani, I. K., Khansarinejad, B., Ghazavi, A., & Mosayebi, G. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102437 · Cited by 160
Minervina, A. A., Komech, E. A., Titov, A., Koraichi, M. B., Rosati, E., Mamedov, I. Z., Franke, A., Efimov, G. A., Chudakov, D. M., Mora, T., et al. (2021) · eLife · doi:10.7554/elife.63502 · Cited by 160
Brochot, É., Demey, B., Touzé, A., Belouzard, S., Dubuisson, J., Schmit, J. L., Duverlie, G., François, C., Castelain, S., & Helle, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.584251 · Cited by 159
Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?
Tiberghien, P., de Lamballerie, X. N., Morel, P., Gallian, P., Lacombe, K., & Yazdanpanah, Y. (2020) · Vox Sanguinis · doi:10.1111/vox.12926 · Cited by 155
Worse progression of COVID‐19 in men: Is testosterone a key factor?
Giagulli, V. A., Guastamacchia, E., Magrone, T., Jirillo, E., Lisco, G., Pergola, G. D., & Triggiani, V. (2020) · Andrology · doi:10.1111/andr.12836 · Cited by 155
Ward, H., Atchison, C. J., Whitaker, M. D., et al. (2020) · medRxiv · doi:10.1101/2020.08.12.20173690v2 · Cited by 155
Jiang, Y., Wei, X., Guan, J., Qin, S., Wang, Z., Lu, H., Qian, J., Wu, L., Chen, Y., Chen, Y., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108516 · Cited by 153
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Kohmer, N., Westhaus, S., Rühl, C., Ciesek, S., & Rabenau, H. F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26145 · Cited by 147
Zhou, Y., Zhang, Z., Tian, J., & Xiong, S. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2020.03.26 · Cited by 145
Hartman, A. L., Nambulli, S., McMillen, C. M., White, A. G., Tilston‐Lunel, N. L., Albe, J. R., Cottle, E. L., Dunn, M., Frye, L. J., Gilliland, T. H., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008903 · Cited by 145
Luo, M., Liu, J., Jiang, W., Yue, S., Liu, H., & Wei, S. (2020) · JCI Insight · doi:10.1172/jci.insight.139024 · Cited by 142
Reappearance of effector T cells is associated with recovery from COVID-19
Odak, I., Barros‐Martins, J., Bošnjak, B., Stahl, K., David, S., Wiesner, O., Busch, M., Hoeper, M. M., Pink, I., Welte, T., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102885 · Cited by 142
Schwarzkopf, S., Krawczyk, A., Knop, D., Klump, H., Heinold, A., Heinemann, F. M., Thümmler, L., Temme, C., Breyer, M., Witzke, O., et al. (2020) · Emerging infectious diseases · doi:10.3201/2701.203772 · Cited by 140
Klimstra, W. B., Tilston-Lunel, N. L., Nambulli, S., Boslett, J., McMillen, C. M., Gilliland, T., Dunn, M. D., Sun, C., Wheeler, S. E., Wells, A., et al. (2020) · Journal of General Virology · doi:10.1099/jgv.0.001481 · Cited by 137
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
Lee, Y.-L., Liao, C.-H., Liu, P., Cheng, C., Chung, M., Liu, C.-E., Chang, S., & Hsueh, P. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.019 · Cited by 137
den Hartog, G., Schepp, R. M., Kuijer, M., GeurtsvanKessel, C., van Beek, J., Rots, N., Koopmans, M. P. G., van der Klis, F. R. M., & van Binnendijk, R. S. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa479 · Cited by 137
Galson, J. D., Schätzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J. C., James, L. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.605170 · Cited by 136
Zhang, G., Nie, S., Zhang, Z., & Zhang, Z. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa229 · Cited by 135
Wang, W., Su, B., Pang, L., Qiao, L., Feng, Y., Ouyang, Y., Guo, X., Shi, H., Wei, F., Su, X., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0447-2 · Cited by 134
Zhang, L., Pang, R., Xue, X., Bao, J., Ye, S., Dai, Y., Zheng, Y., Fu, Q., Hu, Z., & Yi, Y. (2020) · Aging · doi:10.18632/aging.103102 · Cited by 133
Ogbe, A., Kronsteiner, B., Skelly, D., Pace, M. J., Brown, A., Adland, E., Adair, K., Akhter, H. D., Ali, M., Ali, S.-E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21856-3 · Cited by 133
Ouyang, Y., Yin, J., Wang, W., Shi, H., Shi, Y., Xu, B., Qiao, L., Feng, Y., Pang, L., Wei, F., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa462 · Cited by 132
Mehta, P., Porter, J. C., Manson, J. J., Isaacs, J. D., Openshaw, P., McInnes, I. B., Summers, C., & Chambers, R. C. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30267-8 · Cited by 131
Flower, B., Brown, J. C., Simmons, B., Moshe, M., Frise, R., Penn, R., Kugathasan, R., Petersen, C., Daunt, A., Ashby, D., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215732 · Cited by 126
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease
Wang, P., Liu, L., Nair, M. S., Yin, M. T., Luo, Y., Wang, Q., Yuan, T., Mori, K., Solis, A. G., Yamashita, M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1823890 · Cited by 122
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Siracusano, G., Pastori, C., & Lopalco, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01049 · Cited by 110
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Fafi-Kremer, S., Bruel, T., Madec, Y., Grant, R., Tondeur, L., Grzelak, L., Staropoli, I., Anna, F., Souque, P., Fernandes-Pellerin, S., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102915 · Cited by 108
IL-6 blocks a discrete early step in lymphopoiesis
Maeda, K., Baba, Y., Nagai, Y., Miyazaki, K., Malykhin, A., Nakamura, K., Kincade, P. W., Sakaguchi, N., & Coggeshall, K. M. (2005) · Blood · doi:10.1182/blood-2005-02-0456 · Cited by 108
Decreased T cell populations contribute to the increased severity of COVID-19
Liu, R., Wang, Y., Li, J., Han, H. W., Xia, Z., Liu, F., Wu, K., Yang, L., Liu, X., & Zhu, C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.019 · Cited by 106
Jääskeläinen, A. J., Kekäläinen, E., Kallio‐Kokko, H., Mannonen, L., Kortela, E., Vapalahti, O., Kurkela, S., & Lappalainen, M. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.18.2000603 · Cited by 103
Schwarzkopf, S., Krawczyk, A., Knop, D., Klump, H., Heinold, A., Heinemann, F. M., Thümmler, L., Temme, C., Breyer, M., Witzke, O., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2701.203772 · Cited by 101
Long‐term coexistence of SARS‐CoV‐2 with antibody response in COVID‐19 patients
Wang, B., Wang, L., Kong, X., Geng, J., Xiao, D., Ma, C., Jiang, X., & Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25946 · Cited by 97
Wyllie, D., Jones, H. E., Mulchandani, R., Trickey, A., Taylor-Phillips, S., Brooks, T., Charlett, A., Ades, A., EDSAB-HOME investigators, Moore, P., et al. (2020) · doi:10.1101/2020.11.02.20222778 · Cited by 96
Patterson, B. K., Seethamraju, H., Dhody, K., Corley, M. J., Kazempour, K., Lalezari, J., Pang, A. P. S., Sugai, C. K., Francisco, E. B., Pise, A., et al. (2020) · medRxiv · doi:10.1101/2020.05.02.20084673 · Cited by 95
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Anderson, D. E., Tan, C. W., Chia, W. N., Young, B. E., Linster, M., Low, J. G. H., Tan, Y., Chen, M. I.-C., Smith, G. J. D., Leo, Y., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1761267 · Cited by 94
The clinical and immunological features of pediatric COVID-19 patients in China
Chen, J., Zhang, Z., Chen, Y., Long, Q., Tian, W., Deng, H., Hu, J., Zhang, X., Pu-Liao, Xiang, J., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.03.008 · Cited by 93
Thompson, C., Grayson, N. E., Paton, R. S., Bolton, J. S., Lourenço, J., Penman, B. S., Lee, L. N., Odon, V., Mongkolsapaya, J., Chinnakannan, S. K., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.42.2000685 · Cited by 93
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
Kang, C. K., Han, G.-C., Kim, M., Kim, G., Shin, H. M., Song, K., Choe, P. G., Park, W. B., Kim, E. S., Kim, H. B., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.106 · Cited by 91
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
Soler, L. F., Daguer, J., Barluenga, S., Vadas, O., Cohen, P., Pagano, S., Yerly, S., Kaiser, L., Vuilleumier, N., & Winssinger, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238089 · Cited by 91
Rosella, L., Bowman, C., Pach, B., Morgan, S., Fitzpatrick, T., & Goel, V. (2016) · Public Health · doi:10.1016/j.puhe.2015.10.027 · Cited by 90
Harvala, H., Robb, M. L., Watkins, N. A., Ijaz, S., Dicks, S., Patel, M., Supasa, P., Dejnirattisai, W., Liu, C., Mongkolsapaya, J., et al. (2020) · Transfusion Medicine · doi:10.1111/tme.12746 · Cited by 86
Varnaitė, R., García, M., Glans, H., Maleki, K. T., Sandberg, J. T., Tynell, J., Christ, W., Lagerqvist, N., Ásgeirsson, H., Ljunggren, H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000717 · Cited by 84
Che, Y., Liu, X., Pu, Y., Zhou, M., Zhao, Z., Jiang, R., Yin, Z., Xu, M., Yin, Q., Wang, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1703 · Cited by 80
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
Choe, P. G., Kang, C. K., Suh, H. J., Jung, J., Kang, E., Lee, S. Y., Song, K., Kim, H. B., Kim, N. J., Park, W. B., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2610.202211 · Cited by 79
In-depth virological assessment of kidney transplant recipients with COVID-19
Benotmane, I., Gautier-Vargas, G., Wendling, M.-J., Perrin, P., Velay, A., Bassand, X., Bedo, D., Baldacini, C., Sagnard, M., Bozman, D.-F., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16251 · Cited by 79
Vogelzang, E. H., Loeff, F. C., Derksen, N. I. L., Kruithof, S., Heer, P. O., van Mierlo, G. J., Linty, F., Mok, J. Y., van Esch, W. J. E., de Bruin, S., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000767 · Cited by 78
SARS-CoV-2 uses CD4 to infect T helper lymphocytes
Brunetti, N. S., Davanzo, G. G., de Moraes, D., Ferrari, A., de Souza, G. F., Muraro, S. P., Knittel, T. L., Boldrini, V. D. O., Monteiro, L. D. B., Virgílio-da-Silva, J. V., et al. (2023) · eLife · doi:10.7554/elife.84790 · Cited by 78
A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
Payen, D. M., Cravat, M., Maadadi, H., Didelot, C., Prosic, L., Dupuis, C., Losser, M.-R., & Bittencourt, M. D. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580250 · Cited by 77
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Staines, H. M., Kirwan, D. E., Clark, D. J., Adams, E. R., Augustin, Y. S., Byrne, R. L., Cocozza, M., Cubas-Atienzar, A. I., Cuevas, L. E., Cusinato, M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203074 · Cited by 77
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers
Xiao, T., Wang, Y., Yuan, J., Ye, H., Wei, L., Liao, X., Wang, H., Qian, S., Wang, Z., Liu, L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595773 · Cited by 75
Clinical Analysis of 25 COVID-19 Infections in Children
Bai, K., Liu, W., Liu, C., Fu, Y., Hu, J., Qin, Y., Zhang, Q., Chen, H., Xu, F., & Li, C. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002740 · Cited by 74
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression
Shen, L., Wang, C., Zhao, J., Tang, X., Shen, Y., Lu, M., Ding, Z., Huang, C., Zhang, J., Li, S., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1766382 · Cited by 70
Dingens, A. S., Crawford, K. H. D., Adler, A., Steele, S. L., Lacombe, K., Eguia, R. T., Amanat, F., Walls, A. C., Wolf, C. R., Murphy, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18178-1 · Cited by 69
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff
Schmidt, S. B., Grüter, L., Boltzmann, M., & Rollnik, J. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235417 · Cited by 67
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
Liu, P., Cai, J., Jia, R., Xia, S., Wang, X., Cao, L., Zeng, M., & Xu, J. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1772677 · Cited by 65
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters
Brocato, R., Principe, L. M., Kim, R. K., Zeng, X.-K., Williams, J. A., Liu, Y.-N., Li, R., Smith, J. M., Golden, J., Gangemi, D., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01683-20 · Cited by 64
Cited by
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Stein, C., Nassereldine, H., Sorensen, R. J. D., Amlag, J. O., Bisignano, C., Byrne, S., Castro, E., Coberly, K., Collins, J. K., Dalos, J., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02465-5 · Cited by 412
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244126 · Cited by 374
Self-citationCorrelates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 298
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Chen, X., Chen, Z., Azman, A. S., Deng, X., Sun, R., Zhao, Z., Zheng, N., Chen, X., Lu, W., Zhuang, T., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00026-7 · Cited by 239
Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays
Dimech, W., Curley, S., Subissi, L., Ströher, U., Perkins, M. D., & Cunningham, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05101-22 · Cited by 4
Metadata
- Authors
- Shrotri, M., van Schalkwyk, M. C. I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., Maher, J., Shields, A. M., Amirthalingam, G., Peacock, S. J., & Ismail, S. A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-01-25
- Volume
- 16
- Issue
- 1
- Pages
- e0245532
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W3115281787
- Cited by
- 350
- References
- 251
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.